Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006255
What this trial is testing

Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases

Who this might be right for
Kidney CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 17
Not applicableNot Yet RecruitingNCT07497958
What this trial is testing

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma (RCC)Renal Function Abnormal
Sun Yat-sen University 174
Testing effectiveness (Phase 2)Looking for participantsNCT06255223
What this trial is testing

Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

Who this might be right for
Renal Cell CarcinomaRadiotherapyImmune Checkpoint Inhibitor
Jinling Hospital, China 35
Testing effectiveness (Phase 2)Ended earlyNCT00684996
What this trial is testing

Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerRenal Cell CarcinomaStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01297244
What this trial is testing

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 105
Not applicableUnknownNCT03928964
What this trial is testing

MEtatastic Renal Carcinoma LINes

Who this might be right for
Renal Cell Carcinoma
Centre Hospitalier Universitaire de Besancon 440
Large-scale testing (Phase 3)Looking for participantsNCT06750419
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 82
Large-scale testing (Phase 3)Ended earlyNCT01582672
What this trial is testing

Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell CarcinomaRenal Cell CarcinomaMetastatic Renal Cell Carcinoma
Argos Therapeutics 462
Testing effectiveness (Phase 2)Study completedNCT00923130
What this trial is testing

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT03341845
What this trial is testing

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 40
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)Study completedNCT00003928
What this trial is testing

Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 32
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Study completedNCT00003553
What this trial is testing

Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Heart, Lung, and Blood Institute (NHLBI) 156
Not applicableLooking for participantsNCT05621837
What this trial is testing

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Who this might be right for
MelanomaBreast CancerRenal Cell Carcinoma+4 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1,000
Early research (Phase 1)Study completedNCT00625456
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

Who this might be right for
MelanomaLung CancerRenal Cell Carcinoma+1 more
Jennerex Biotherapeutics 23
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Study completedNCT00012337
What this trial is testing

ZD 1839 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Next Page